Toxicity with proton therapy for oral and/or oropharyngeal cancers: A scoping review
Journal of Oral Pathology & Medicine · 2023
DOI: 10.1111/jop.13426 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Oral Pathology & Medicine, 2023. Verfasst von Sneha Sethi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Adelaide Dental School, University of Adelaide, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Proton Therapy, Oropharyngeal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Oral and/or oropharyngeal cancers account for approximately 2% of all malignancies, with variation across age groups, genders, and geographic locations. Treatments for oral and/or oropharyngeal cancers usually consist of a combination of surgical excision most commonly followed by radiotherapy ± chemotherapy and/or immunotherapy/biotherapy depending on the nature of the malignancy. The significant morbidity caused by high‐dose radiotherapy to the head and neck region is widely observed. Proton therapy is a promising treatment option that localises a proton beam to direct radiation at a specific target, with reduced irradiation to adjacent structures.
Method
The objective was to explore the toxicity associated with proton therapy for adults with oral and/or oropharyngeal cancer. Eligibility criteria included full‐text articles, English articles, published between up till 7 January 2023. Databases included PubMed, Scopus, Web of Science, Embase, and Scopus.
Results
The systematic search identified 345 studies and a total of 18 studies were included after two independent reviewers completed title, abstract, and full‐text screening. Included studies were from four countries, and median participant age range was 53.3 to 66 years. The most commonly reported acute toxic effects included dysphagia, radiation dermatitis, oral mucositis, dysgeusia, and alopecia.
Conclusion
Proton therapy is an evolving cancer treatment technique that has diverse advantages over conventional radiotherapy and chemotherapy. This review provides evidence that supports that proton therapy has an improved acute toxicity profile compared to radiotherapy to treat oral and/or oropharyngeal cancer individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Adelaide Dental School, University of Adelaide, Adelaide, South Australia, Australia.
- Department of Paediatric Dentistry, Women's and Children's Hospital, Adelaide, South Australia, Australia.
ORCID-Profile: Sneha Sethi, Emilija Jensen
Zitieren
APA
Sethi, S., O'Neil, M., Jensen, E., Smart, G., & Poirier, B. (2023). Toxicity with proton therapy for oral and/or oropharyngeal cancers: A scoping review. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13426
Vancouver
Sethi S, O'Neil M, Jensen E, Smart G, Poirier B. Toxicity with proton therapy for oral and/or oropharyngeal cancers: A scoping review. Journal of Oral Pathology & Medicine. 2023. doi:10.1111/jop.13426
BibTeX
@article{Sethi2023,
author = {Sethi, Sneha and O'Neil, Mitchel and Jensen, Emilija and Smart, Gabrielle and Poirier, Brianna},
title = {Toxicity with proton therapy for oral and/or oropharyngeal cancers: A scoping review},
journal = {Journal of Oral Pathology & Medicine},
year = {2023},
doi = {10.1111/jop.13426}
}
EUVIMED